How Analysts Rated Huntington Bancshares Incorporated (NASDAQ:HBAN) Last Week?

Ruben Hill
April 21, 2018

Susquehanna Grp Inc Llp reported 234,685 shares. The institutional investor held 137,300 shares of the major banks company at the end of 2017Q4, valued at $2.00 million, up from 41,189 at the end of the previous reported quarter. The firm has a market cap of $14.17 billion, a price-to-earnings ratio of 19.33 and a beta of 1.24. (NYSE:QEP) went up during the trading session by $0.16 on Thursday, trading at $12.27. About 6.78M shares traded. It has outperformed by 3.12% the S&P500.

Hawk Ridge Management Llc increased its stake in Orion Engineered Carbons S A (OEC) by 4.93% based on its latest 2017Q4 regulatory filing with the SEC. Its down 15% from 4.40 million shares previously. It also reduced General Electric (NYSE:GE) stake by 36,410 shares and now owns 43,303 shares. Foothills Asset Management Ltd who had been investing in Honeywell Int'l for a number of months, seems to be less bullish one the $110.86B market cap company. This represents a $0.44 annualized dividend and a yield of 2.98%. (NYSE:CNP), its shares were trading at $26.98 a retreat of $-0.16, on the trading floor. Orion Engineered Carbons, S.A. (NYSE:OEC) has risen 34.29% since April 20, 2017 and is uptrending. It has outperformed by 4.39% the S&P500.

Since March 15, 2018, it had 2 insider purchases, and 0 sales for $75,760 activity. PARDO JAIME CHICO /FA sold $448,440 worth of stock.

Investors sentiment increased to 1.36 in 2017 Q4. Let's take a quick look at some other time spans, the 12 months price index reads 1.12, the 24 month is 0.79. It fall, as 42 investors sold HON shares while 490 reduced holdings. Fmr Ltd Llc has 97.06 million shares. (NASDAQ:ECYT). Renaissance Techs Limited Liability Corp owns 293,580 shares. (NYSE:HON). Family Firm owns 2,138 shares for 0.13% of their portfolio. Axa has invested 0% of its portfolio in Endocyte, Inc. (NYSE:HON). Huntington Bancorp reported 1.06% in Honeywell International Inc. Chevy Chase reported 939,178 shares. Bridgeway Mngmt Inc invested in 0.01% or 294,800 shares. (NYSE:BRS) for 1.05M shares. State Bank Of America De holds 0% or 67,510 shares. Therefore 73% are positive. Endocyte had 11 analyst reports since August 5, 2015 according to SRatingsIntel. On Wednesday, October 11 the stock rating was maintained by Robert W. Baird with "Buy". The firm earned "Overweight" rating on Tuesday, March 6 by JP Morgan. The stock of Endocyte, Inc. The rating was upgraded by Goldman Sachs to "Buy" on Friday, July 14. The rating was maintained by FBR Capital on Friday, January 22 with "Mkt Perform". The rating was maintained by Keefe Bruyette & Woods on Monday, February 26 with "Hold". The firm has "Buy" rating by Stifel Nicolaus given on Tuesday, April 3. The company's Consumer and Business Banking segment offers financial products and services, such as checking accounts, savings accounts, money market accounts, certificates of deposit, consumer loans, and small business loans; and investments, mortgages, insurance, interest rate risk protection, and foreign exchange and treasury management services. The rating was maintained by Stifel Nicolaus with "Buy" on Thursday, August 24. (NYSE:JPM) by 4,389 shares to 55,216 shares, valued at $5.91M in 2017Q4, according to the filing. SWS Partners bought a new stake in shares of Huntington Bancshares during the 4th quarter valued at about $126,000.

Huntington Bancshares (NASDAQ:HBAN) last released its quarterly earnings data on Tuesday, January 23rd. Therefore 56% are positive. Bristow Group had 30 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was initiated by Credit Suisse with "Outperform" on Thursday, January 21. BMO Capital Markets maintained it with "Hold" rating and $18.0 target in Tuesday, January 23 report. Piper Jaffray has "Buy" rating and $18.0 target. Huntington Bancshares now has a consensus rating of "Buy" and a consensus price target of $16.98. The rating was downgraded by Wedbush on Monday, June 5 to "Neutral". The stock has "Hold" rating by Keefe Bruyette & Woods on Wednesday, December 13. The stock of Huntington Bancshares Incorporated (NASDAQ:HBAN) has "Buy" rating given on Thursday, July 27 by RBC Capital Markets. Initiated the shares of QEP Resources, Neutral when they released a research note on February 6th, 2018, but they now have set a price target of $10.50.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.26, from 0.96 in 2017Q3.

On April 19, 2018, Huntington Bancshares Incorporated announced that the board of directors declared a quarterly cash dividend on its common stock (NASDAQ: HBAN) of $0.11 per common share, unchanged from the prior quarter. 22 funds opened positions while 32 raised stakes. (NYSE:BRS). Invesco Ltd reported 269,740 shares or 0% of all its holdings. Cambridge Research Advsrs has invested 0.02% of its portfolio in Huntington Bancshares Incorporated (NASDAQ:HBAN). Td Asset has 0.01% invested in Huntington Bancshares Incorporated (NASDAQ:HBAN). Lumbard & Kellner Limited Com has invested 1.75% in Huntington Bancshares Incorporated (NASDAQ:HBAN). Dynamic Limited, a United Kingdom-based fund reported 35,300 shares. Comerica National Bank accumulated 33,080 shares or 0% of the stock. First Bankshares Of Omaha owns 336,003 shares. The bank reported $0.26 EPS for the quarter, meeting the Zacks' consensus estimate of $0.26. Huntington Bancshares Incorporated (NASDAQ:HBAN) has risen 14.67% since April 20, 2017 and is uptrending. D E Shaw And Communications accumulated 0.01% or 480,174 shares. Winslow Evans And Crocker has 0% invested in Huntington Bancshares Incorporated (NASDAQ:HBAN). (NASDAQ:ECYT). Financial Architects holds 0% of its portfolio in Endocyte, Inc.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Other reports by Click Lancashire

Discuss This Article